Zhao Xiaoying – Trademark Portfolio

Entity Type: 01

Zhao Xiaoying holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include FADENRY and COLEOLOGY. The owner is based in Nanyang City, Henan Province.

No. 479, Duzhuang Village, Qinghua Town, Wolong District

Nanyang City, Henan Province 473001 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

COLEOLOGY
COLEOLOGY
Registered 2025
FADENRY
FADENRY
Registered 2020

Trademark Classifications

Zhao Xiaoying's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Zhao Xiaoying have?

Zhao Xiaoying has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Zhao Xiaoying file in?

Zhao Xiaoying files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Zhao Xiaoying's most well-known trademarks?

Zhao Xiaoying's registered trademark portfolio includes well-known marks such as FADENRY and COLEOLOGY. These are among 2 currently registered trademarks in the portfolio.

What is Zhao Xiaoying's trademark registration success rate?

Zhao Xiaoying has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.